Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Crews

Showing results (71-80 of 173) with videos related to

Pageof 18
Sort By:
International Journal of Cancer|July 9, 1992
A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell linesJ R Crews, L A Maier, Y H Yu, et al.
Haematologica|March 2, 2019
Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinibDylan Graetz, Kristine R Crews, Elizabeth M Azzato, et al.
American Journal of Obstetrics and Gynecology|September 11, 1991
Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell linesF L Tyson, C M Boyer, R Kaufman, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2005
Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumorsCarlos Rodriguez-Galindo, Kristine R Crews, Clinton F Stewart, et al.
Clinical Pharmacology and Therapeutics|August 8, 2008
Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemiaG Stocco, M H Cheok, K R Crews, et al.
Leukemia|November 13, 2010
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivityS-H Chen, W Yang, Y Fan, et al.
Journal of Pediatric Hematology/Oncology Nursing|March 31, 2026
Precision-Based Care: A Multidisciplinary ApproachBelinda N Mandrell, Liza-Marie Johnson, Jami S Gattuso, et al.
Clinical Pharmacology and Therapeutics|July 28, 2021
Advancing Precision Medicine Through the New Pharmacogenomics Global Research NetworkKathleen M Giacomini, Jason H Karnes, Kristine R Crews, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 26, 2019
Challenges in clinical implementation of CYP2D6 genotyping: choice of variants to test affects phenotype determinationKeito Hoshitsuki, Kristine R Crews, Wenjian Yang, et al.
Cancer Research|June 1, 1990
Use of immunotoxins in combination to inhibit clonogenic growth of human breast carcinoma cellsY H Yu, J R Crews, K Cooper, et al.
Pageof 18

Showing results (71-80 of 173) with videos related to

Sort By:
Pageof 18
International Journal of Cancer|July 9, 1992
A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast-cancer cell linesJ R Crews, L A Maier, Y H Yu, et al.
Haematologica|March 2, 2019
Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinibDylan Graetz, Kristine R Crews, Elizabeth M Azzato, et al.
American Journal of Obstetrics and Gynecology|September 11, 1991
Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell linesF L Tyson, C M Boyer, R Kaufman, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2005
Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumorsCarlos Rodriguez-Galindo, Kristine R Crews, Clinton F Stewart, et al.
Clinical Pharmacology and Therapeutics|August 8, 2008
Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemiaG Stocco, M H Cheok, K R Crews, et al.
Leukemia|November 13, 2010
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivityS-H Chen, W Yang, Y Fan, et al.
Journal of Pediatric Hematology/Oncology Nursing|March 31, 2026
Precision-Based Care: A Multidisciplinary ApproachBelinda N Mandrell, Liza-Marie Johnson, Jami S Gattuso, et al.
Clinical Pharmacology and Therapeutics|July 28, 2021
Advancing Precision Medicine Through the New Pharmacogenomics Global Research NetworkKathleen M Giacomini, Jason H Karnes, Kristine R Crews, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 26, 2019
Challenges in clinical implementation of CYP2D6 genotyping: choice of variants to test affects phenotype determinationKeito Hoshitsuki, Kristine R Crews, Wenjian Yang, et al.
Cancer Research|June 1, 1990
Use of immunotoxins in combination to inhibit clonogenic growth of human breast carcinoma cellsY H Yu, J R Crews, K Cooper, et al.
Pageof 18